Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

NCT05256641

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

University of Oklahoma Oklahoma City, Oklahoma, United States

View Trial Details

Recruiting

Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial

NCT06326008

Conditions: Acute Lymphoblastic Leukemia, in Relapse, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

NCT07042438

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

NCT05800366

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Miami Sylvester Cancer Center Miami, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL

NCT07448324

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

NCT06486051

Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Christchurch Hospital Christchurch, Christchurch Central, New Zealand

Wellington Hospital Newtown, Wellington Region, New Zealand

Auckland City Hospital Auckland, New Zealand

View Trial Details

Recruiting

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

NCT04231877

Conditions: ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL

NCT07441993

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

Xiangyang Central Hospital Xiangyang, Hubei, China

View all 14 locations

View Trial Details

Recruiting

Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma

NCT07443514

Conditions: Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, +16 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

Recommendations for the Treatment of Children With Burkitt's Lymphoma

NCT04425421

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +14 more
Locations: Hopital Yalgado Ouedraogo Ouagadougou, Burkina Faso

CHU de Treichville à ABIDJAN Abidjan, Côte d’Ivoire

Cliniques Universitaires de Kinshasa Kinshasa, Kinshasa City, Democratic Republic of the Congo

Cliniques Universitaires de Lubumbashi (CUL) Lubumbashi, Democratic Republic of the Congo

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions